×
Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF
$ 40.00
Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF quantity
$ 40.00
×
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF
$ 40.00
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF quantity
$ 40.00
×
Improving Effective Mental Health Consultation for Rural Older Adults Living With Depression and Pain: Learning From the Experiences of Rural Primary Care Physicians PDF
$ 40.00
Improving Effective Mental Health Consultation for Rural Older Adults Living With Depression and Pain: Learning From the Experiences of Rural Primary Care Physicians PDF quantity
$ 40.00
×
New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists PDF
$ 40.00
New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting: A Great Opportunity for Early Career Psychiatrists PDF quantity
$ 40.00
×
Predominance of Symptoms Over Time in Early-Onset Psychosis: A Principal Component Factor Analysis of the Positive and Negative Syndrome Scale PDF
$ 40.00
Predominance of Symptoms Over Time in Early-Onset Psychosis: A Principal Component Factor Analysis of the Positive and Negative Syndrome Scale PDF quantity
$ 40.00
×
Integrating Primary Care Services Into Psychiatric Care Settings: A Review of the Literature PDF
$ 40.00
Integrating Primary Care Services Into Psychiatric Care Settings: A Review of the Literature PDF quantity
$ 40.00
×
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF
$ 40.00
A Randomized Pilot Study of the Efficacy and Safety of ABT-089, a Novel α4β2 Neuronal Nicotinic Receptor Agonist, in Adults With Attention-Deficit/Hyperactivity Disorder PDF quantity
$ 40.00
×
Prevalence and Clinical Correlates of Irritability in Major Depressive Disorder: A Preliminary Report From the Sequenced Treatment Alternatives to Relieve Depression Study PDF
$ 40.00
Prevalence and Clinical Correlates of Irritability in Major Depressive Disorder: A Preliminary Report From the Sequenced Treatment Alternatives to Relieve Depression Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
